Maestro Brain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ClearPoint Neuro announced today that it priced an underwritten public offering worth approximately $15 million.

Operator Greetings. Welcome to ClearPoint Neuro Inc.'s first-quarter financial results conference call. [Operator instructions] Please note, this conference is being recorded. Comments made on this call may include statements that are forward-looking within the meaning of the securities laws. These forward-looking statements may include, without limitation, statements related to anticipated industry trends, the company's plans, prospects, and strategies, both preliminary and projected, and management's expectations, beliefs, estimates, or projections regarding future results of operations. Ac...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips ClearPoint Neuro, Inc.February 18, 2021 GMT Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022 IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a worldwide license and research agreement with Philips,...